A Review of COVID-19 and Tuberculosis Coinfections: Epidemiological and Clinical Interactions in India

Dr. Sulagna Pattajoshi

Abstract: COVID-19 and Tuberculosis are respiratory communicable diseases with a massive spread in the world. This review explores the interactions between COVID19 and tuberculosis TB in the Indian context, highlighting the epidemiological, clinical, and socioeconomic impacts of coinfections. Open access, English language articles published within 2011-2022 with context for Tuberculosis and COVID-19 in India, were identified comprehensively from sources like PubMed, Lit-Covid, and Google scholar, using search terms ?COVID-19? ?Tb? and ?India?. The article examines similarities in symptoms and transmission methods between the two diseases, evaluates the challenges posed by their concurrent presence, and discusses the implications for public health in India. The review further provides comparative data on the incidence, treatment, and prevention strategies for COVID-19 and TB, and offers recommendations for mitigating the impact of their coinfection. It also provides an account of the clinical and social impacts of the co-infection. It concludes on the need to continue research on each of the diseases-Tb and COVID-19 for early diagnosis, appropriate treatment, to prevent them individually as well their coinfections.

Keywords: Tb, TB, Tuberculosis, COVID-19, coronavirus

How to Cite?: Dr. Sulagna Pattajoshi, "A Review of COVID-19 and Tuberculosis Coinfections: Epidemiological and Clinical Interactions in India ", Volume 13 Issue 9, September 2024, International Journal of Science and Research (IJSR), Pages: 455-464, https://www.ijsr.net/getabstract.php?paperid=SR24823134123, DOI: https://dx.doi.org/10.21275/SR24823134123